FHL2 binds calcineurin and represses pathological cardiac growth.
about
Corresponding morphological and molecular indicators of crude oil toxicity to the developing hearts of mahi mahi.Structure and ligand-binding mechanism of the human OX1 and OX2 orexin receptorsGenetic epidemiology of titin-truncating variants in the etiology of dilated cardiomyopathy.Sumoylation-independent activation of Calcineurin-NFAT-signaling via SUMO2 mediates cardiomyocyte hypertrophy.Cypher/ZASP is a novel A-kinase anchoring protein.Deleting titin's I-band/A-band junction reveals critical roles for titin in biomechanical sensing and cardiac function.FHL2 expression and variants in hypertrophic cardiomyopathy.Targeted inhibition of ANKRD1 disrupts sarcomeric ERK-GATA4 signal transduction and abrogates phenylephrine-induced cardiomyocyte hypertrophy.Increased myocardial stiffness due to cardiac titin isoform switching in a mouse model of volume overload limits eccentric remodelingFHL2 switches MITF from activator to repressor of Erbin expression during cardiac hypertrophy.Chronic carvedilol treatment partially reverses the right ventricular failure transcriptional profile in experimental pulmonary hypertension.Shortening of the elastic tandem immunoglobulin segment of titin leads to diastolic dysfunction.RBM20, a potential target for treatment of cardiomyopathy via titin isoform switching.Overview of the Muscle Cytoskeleton.The novel cardiac z-disc protein CEFIP regulates cardiomyocyte hypertrophy by modulating calcineurin signaling.Four-and-a-half LIM domains proteins are novel regulators of the protein kinase D pathway in cardiac myocytes.The four and a half LIM-domain 2 controls early cardiac cell commitment and expansion via regulating β-catenin-dependent transcription.SIRT2 deacetylase represses NFAT transcription factor to maintain cardiac homeostasis.
P2860
25ca8a59cf95777cf31e501f78d489839e3d26403b1c0db7ab4f074a9972bb0da37c3935956fea92752aed7b3839cd8574a5542cb948e495fa99a06f79a89b8111afd32e59cf445f0108c141239de6b0c86079a79a7a9c52a7692c4b0583b1d384cf7a57cbbf8df40d8647dcd457814b9a1de3f8e95a1fc9e5259f7861815098f6589e954f01e2fc910eb2a1fed9ac519dc67f92852ca5465ff76d49871efc6a
P248
Q27304878-42D24DAA-E105-4472-9EBF-399F79A55025Q27704228-92A9C3B3-EA1F-42AA-B46A-FADFBB431321Q30234440-05ADB87A-E0AF-4B36-8A5E-85D448747778Q30825127-812074D0-48A5-45D5-9D3C-F3909812CABCQ34368057-C83262C1-1136-4D16-8F8E-6E2517E325A1Q34407578-43A849C7-115D-4F2F-ADE2-0F8DC2C7E63EQ34430364-F24F9552-44AB-4739-8158-FA5E6BB5CA0EQ34467093-89630C95-2E52-4562-92B5-6B35056E53F7Q34995889-92A13695-A948-4BA6-AC7A-096DAB58DA98Q35772405-AAFC5680-6F9A-44E2-BAC6-C7FC4CFA0AB7Q36923968-3458330B-44D2-4482-AB09-639D2DE3AF4DQ37292468-DACCB0C1-8752-4793-81A6-2792D0479352Q38675375-9275FEB5-5E25-4CFE-8A0A-7FE97977010FQ39391006-7A048898-D868-49A3-9422-9988B199B98AQ41706530-B4DEA056-FADE-40EE-8719-A308AC4126DCQ41963142-5F7105D0-F2D0-4197-A8FD-FB565B720741Q42556696-11FCD447-0423-4EA1-A218-946DB624632EQ50026590-7663A68A-C716-4F89-8C82-566A147980E8
P2860
FHL2 binds calcineurin and represses pathological cardiac growth.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
FHL2 binds calcineurin and represses pathological cardiac growth.
@en
FHL2 binds calcineurin and represses pathological cardiac growth.
@nl
type
label
FHL2 binds calcineurin and represses pathological cardiac growth.
@en
FHL2 binds calcineurin and represses pathological cardiac growth.
@nl
prefLabel
FHL2 binds calcineurin and represses pathological cardiac growth.
@en
FHL2 binds calcineurin and represses pathological cardiac growth.
@nl
P2093
P2860
P921
P356
P1476
FHL2 binds calcineurin and represses pathological cardiac growth.
@en
P2093
Berdymammet Hojayev
Beverly A Rothermel
Joseph A Hill
Thomas G Gillette
P2860
P304
P356
10.1128/MCB.05948-11
P407
P577
2012-07-30T00:00:00Z